Background

Stigma related to drug use is a well-documented barrier to engaging and remaining on medication for opioid use disorder (MOUD), yet little is known about how stigma operates across multiple social and institutional settings in low-resource contexts.

Methods

This qualitative study draws on 40 in-depth interviews with current and former MOUD clients and four focus groups with 35 current clients at an opioid treatment clinic in Dar es Salaam, Tanzania. Transcripts were thematically analyzed to explore how stigma influenced MOUD adherence and retention.

Results

Five themes emerged...

Background

Smoking is more common in lower socioeconomic position (SEP) groups, but smoking cessation interventions are less effective for these groups. StopCoach, an mHealth intervention, supports people with lower SEP in quitting smoking. A non-randomized controlled trial found that adding StopCoach to accredited smoking cessation counselling (SCC) led to higher abstinence rates immediately after and one year after SCC, compared to SCC alone. Users also rated its usability, acceptability, and practicality positively. Recent studies show a dose-response relationship, where more mHealth use...

CSUCH’s data visualisation tool can be used to estimate substance use trends across the country. The data helps inform programs, practices, and research to protect communities, save lives, and improve the well-being of people in Canada.

Spotlight: Top 3 causes of death due to substance use in Canada 

More than 200 people died each day due to substance use (SU) in 2020 (the latest year for which data are available). That works out to 73,994 deaths that year. The average age of death due to SU was 45 years. Tobacco use caused 63% (46,366) of SU-related deaths, followed by alcohol at 23%...

Background
Binge drinking, defined as consuming five or more alcoholic drinks in a single session, is a major public health issue. It leads to cognitive and motor impairments and is linked to numerous health problems. This study aims to analyze globally published peer-reviewed literature on binge drinking.

Methods
A thorough search was conducted in the Scopus database using keywords related to binge drinking. Specific criteria were applied to filter the results, resulting in 2,763 relevant research papers. VOSviewer software was used to analyze and visualize connections between these studies...

Background
Cognitive deficits are common in patients with substance use disorder (SUD) and can impact treatment outcomes. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) is a widely used tool that could help identify cognitive impairments in SUD patients. This systematic review examines the RBANS’ effectiveness in detecting cognitive impairment in SUD patients and discusses knowledge gaps and the need for further research.

Methods
A systematic search was conducted in PsycINFO, Medline, and Cochrane databases to find relevant studies on the use of RBANS in SUD...

Background
A non-medicalized safer supply model called a “Compassion Club” has recently been evaluated. The model involved providing rigorously tested and accurately labeled illicit substances to members at cost. Operating for 14 months in Vancouver's Downtown Eastside, the initiative aimed to explore the effects and feasibility of this approach among individuals at risk of fatal overdose.

Methods
At the one-year mark, 43 club members completed a survey for this cross-sectional analysis. Descriptive statistics were used to assess the perceived impact of membership on factors like drug use...

Researchers at Virginia Commonwealth University (VCU) have developed a new version of a medication for opioid use disorder that could offer longer-lasting treatment . Current medications for opioid addiction often require daily doses, but the new formulation of nor-levo-alpha-acetylmethadol (nor-LAAM) is designed to be taken once a month or less frequently. This long-acting medication has shown promise in reducing opioid use and withdrawal symptoms in rodent models. The goal is to provide an alternative to existing treatments like methadone and buprenorphine, which come with barriers such as...